.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
AstraZeneca
Dow
Express Scripts
Cipla
Novartis
Covington
Fish and Richardson
Cantor Fitzgerald
Farmers Insurance

Generated: September 21, 2017

DrugPatentWatch Database Preview

Chartwell Molecules Company Profile

« Back to Dashboard

What is the competitive landscape for CHARTWELL MOLECULES, and what generic and branded alternatives to CHARTWELL MOLECULES drugs are available?

CHARTWELL MOLECULES has twenty-two approved drugs.



Summary for Applicant: Chartwell Molecules

Patents:0
Tradenames:15
Ingredients:15
NDAs:22
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Molecules
METRONIDAZOLE
metronidazole
TABLET;ORAL018930-001Aug 18, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Chartwell Molecules
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
TABLET;ORAL074093-002Nov 5, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Chartwell Molecules
ONDANSETRON
ondansetron
TABLET, ORALLY DISINTEGRATING;ORAL076506-001Dec 26, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe
Chartwell Molecules
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
TABLET;ORAL074093-004Nov 5, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Chartwell Molecules
SULFAMETHOXAZOLE AND TRIMETHOPRIM
sulfamethoxazole; trimethoprim
TABLET;ORAL078060-002Jan 25, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Chartwell Molecules
INDOMETHACIN
indomethacin
CAPSULE;ORAL018829-001Aug 6, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Chartwell Molecules
NAPROXEN
naproxen
TABLET;ORAL074410-002Apr 28, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
Chartwell Molecules
ACYCLOVIR
acyclovir
CAPSULE;ORAL074872-001Apr 22, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Chartwell Molecules
CLONIDINE HYDROCHLORIDE
clonidine hydrochloride
TABLET;ORAL071785-002Apr 5, 1988RXNoNo► Subscribe► Subscribe► Subscribe
Chartwell Molecules
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
TABLET;ORAL074093-003Nov 5, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Teva
Federal Trade Commission
Merck
Covington
Cantor Fitzgerald
McKinsey
McKesson
Baxter
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot